These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 16933589

  • 1. Add-on quetiapine for bipolar depression: a 12-month open-label trial.
    Milev R, Abraham G, Zaheer J.
    Can J Psychiatry; 2006 Jul; 51(8):523-30. PubMed ID: 16933589
    [Abstract] [Full Text] [Related]

  • 2. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M, Brescan DW, Perez DE, DiGiovanni SK, Hattab H, Ray JB, Bingham CR.
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [Abstract] [Full Text] [Related]

  • 3. Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: an open label study.
    Bahk WM, Yoon BH, Lee KU, Chae JH.
    Hum Psychopharmacol; 2004 Apr; 19(3):181-5. PubMed ID: 15079852
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Calabrese JR, Keck PE, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J.
    Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W, BOLDER Study Group.
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
    McConville B, Carrero L, Sweitzer D, Potter L, Chaney R, Foster K, Sorter M, Friedman L, Browne K.
    J Child Adolesc Psychopharmacol; 2003 Jun; 13(1):75-82. PubMed ID: 12804128
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
    Shajahan P, Taylor M.
    J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H.
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [Abstract] [Full Text] [Related]

  • 19. Long-Term use of quetiapine in elderly patients with psychotic disorders.
    Tariot PN, Salzman C, Yeung PP, Pultz J, Rak IW.
    Clin Ther; 2000 Sep; 22(9):1068-84. PubMed ID: 11048905
    [Abstract] [Full Text] [Related]

  • 20. First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo.
    Suppes T, Ketter TA, Gwizdowski IS, Dennehy EB, Hill SJ, Fischer EG, Snow DE, Gonzalez R, Sureddi S, Shivakumar G, Cosgrove VE.
    J Affect Disord; 2013 Aug 15; 150(1):37-43. PubMed ID: 23521871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.